Rheumatoid Arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent joint inflammation, pain, and eventual bone erosion. While pharmacological treatments like Disease-Modifying Antirheumatic Drugs (DMARDs) remain the cornerstone of therapy, many patients seek complementary approaches to manage their symptoms and improve their quality of life.
A recent landmark umbrella review, titled "Effects of nutritional supplements and dietary interventions on rheumatoid arthritis," led by Xue-Er Cheng and a team of researchers from Anhui Medical University, provides a comprehensive look at the current landscape of nutritional science in RA. By synthesizing data from multiple meta-analyses of randomized controlled trials (RCTs), this study offers a critical perspective on what actually works—and how strong the evidence truly is.
To understand the significance of this study, it is important to recognize the "Umbrella Review" format. Unlike a standard meta-analysis that looks at individual trials, an umbrella review synthesizes existing meta-analyses. This provides a "birds-eye view" of the entire field.
The researchers searched major databases (PubMed, Web of Science, Embase, and Cochrane Library) through December 2024. They employed rigorous quality assessment tools:
The review analyzed 14 high-level articles covering a range of interventions, from specific fatty acids to complex dietary patterns. Here is a breakdown of the most significant findings:
TGP emerged as one of the most promising interventions in this review. Derived from the root of Paeonia lactiflora Pall, TGP has been used in traditional medicine for centuries and is now gaining clinical traction.
Omega-3 fatty acids (commonly found in fish oil) have long been touted for their anti-inflammatory properties. The umbrella review confirmed several clinical benefits:
The "gut-joint axis" is a growing area of rheumatology research. This review evaluated the impact of beneficial bacteria on RA patients.
Rather than focusing on a single pill, some meta-analyses looked at whole dietary patterns, such as the Mediterranean diet or specific "anti-inflammatory" protocols.
While the results for PUFAs, TGP, and probiotics are encouraging, the authors highlight a significant caveat: the quality of evidence.
| Quality Rating (AMSTAR 2) | Number of Studies |
|---|---|
| High Quality | 3 |
| Low Quality | 6 |
| Critically Low Quality | 5 |
Of the 14 articles included, only three were rated as high quality. Furthermore, the GRADE assessment for most intervention effects—including the positive results for TGP and probiotics—ranged from "low" to "very low."
This doesn't mean the interventions don't work; rather, it means the current body of research has limitations. These limitations often include:
For those living with RA, this umbrella review offers a nuanced "green light" to certain supplements, provided they are used as adjuncts to, not replacements for, conventional medical treatment.
If a patient is struggling with morning stiffness or high inflammatory markers despite DMARD therapy, discussing PUFAs (Fish Oil) or TGP with a rheumatologist is supported by this evidence. These supplements appear to target the mechanical and biochemical aspects of the disease (joint counts and ESR).
For patients whose primary struggle is pain management (VAS scores), probiotics may offer a low-risk complementary path to relief. Given that RA patients are often on medications that can affect the gut, supporting the microbiome may have secondary health benefits beyond joint health.
The review by Cheng et al. serves as a vital "state of the union" for nutritional rheumatology. It confirms that the food we eat and the supplements we take are not merely "lifestyle choices" but are bioactive interventions that can influence the course of an autoimmune disease.
The Bottom Line: PUFAs, probiotics, TGP, and anti-inflammatory diets show genuine promise in reducing RA symptoms and inflammatory markers. However, because much of the evidence is currently rated as "low quality," patients should approach these interventions with realistic expectations.
As we move toward 2025 and beyond, the medical community needs more high-quality, long-term RCTs and "real-world evidence" to turn these promising trends into standardized clinical guidelines. Until then, nutrition remains a powerful, albeit supplementary, tool in the RA toolkit.
Reference: Cheng, X. E., et al. (2025). Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials. Autoimmunity Reviews. DOI: 10.1016/j.autrev.2025.103792